A 2:1 NR and pterostilbene composition raises NAD+ and lowers nitric oxide in chondrocytes to slow osteoarthritis progression.
Blocking RT-driven lipid metabolism with a FASN inhibitor helps PD-1 therapy overcome glioblastoma immunosuppression and resistance.
A glyceryl ether-phospholipid composition forms a water-triggered film that stays on mucosa and skin longer to protect inflamed tissue.
A multi-herb analgesic composition combines complementary pathways to relieve pain while reducing opioid use and withdrawal symptoms.
A segmented oral formulation combines guaifenesin, naproxen, and dextromethorphan to balance rapid onset with up to 12-hour relief.